Premium
Immune‐related hematologic adverse events in the context of immune checkpoint inhibitor therapy
Author(s) -
Saliba Antoine N.,
Xie Zhuoer,
Higgins Alexandra S.,
AndradeGonzalez Xavier A.,
FuentesBayne Harry E.,
Hampel Paul J.,
Kankeu Fonkoua Lionel A.,
Childs Daniel S.,
Rakshit Sagar,
Bezerra Evandro D.,
Kommalapati Anuhya,
Lou Yanyan,
Rivera Candido E.,
Price Katharine A.,
Chintakuntlawar Ashish,
Yan Yiyi,
Schwecke Anna J.,
Block Matthew S.,
Thanarajasingam Uma,
Thanarajasingam Gita,
WolanskyjSpinner Alexandra P.,
Marshall Ariela L.,
Kottschade Lisa A.,
Go Ronald S.,
AlKali Aref
Publication year - 2021
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26273
Subject(s) - medicine , adverse effect , neutropenia , immunology , pancytopenia , autoimmune hemolytic anemia , immune system , pure red cell aplasia , lymphocytopenia , aplastic anemia , anemia , chemotherapy , antibody , lymphocyte , bone marrow